Skalska, L.* ; Begley, V.* ; Beltran, M.* ; Lukauskas, S. ; Khandelwal, G.* ; Faull, P.* ; Bhamra, A.* ; Tavares, M.* ; Wellman, R.* ; Tvardovskiy, A. ; Foster, B. ; Ruiz de Los Mozos, I.* ; Herrero, J.* ; Surinova, S.* ; Snijders, A.P.* ; Bartke, T. ; Jenner, R.G.*
Nascent RNA antagonizes the interaction of a set of regulatory proteins with chromatin.
Mol. Cell 81, 2944-2959.e10 (2021)
A number of regulatory factors are recruited to chromatin by specialized RNAs. Whether RNA has a more general role in regulating the interaction of proteins with chromatin has not been determined. We used proteomics methods to measure the global impact of nascent RNA on chromatin in embryonic stem cells. Surprisingly, we found that nascent RNA primarily antagonized the interaction of chromatin modifiers and transcriptional regulators with chromatin. Transcriptional inhibition and RNA degradation induced recruitment of a set of transcriptional regulators, chromatin modifiers, nucleosome remodelers, and regulators of higher-order structure. RNA directly bound to factors, including BAF, NuRD, EHMT1, and INO80 and inhibited their interaction with nucleosomes. The transcriptional elongation factor P-TEFb directly bound pre-mRNA, and its recruitment to chromatin upon Pol II inhibition was regulated by the 7SK ribonucleoprotein complex. We postulate that by antagonizing the interaction of regulatory proteins with chromatin, nascent RNA links transcriptional output with chromatin composition.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Rna Polymerase Ii ; Rnase ; Chromatin ; Histone Modification ; Nascent Rna ; Nucleosome ; Nucleosome Remodeller ; Pre-mrna ; Transcription Factor ; Transcriptional Elongation; Repressive Complex 2; Polymerase-ii; P-tefb; Pervasive Transcription; Binding Protein; Snrnp Complex; Web Server; 7sk Snrnp; Hiv-1 Tat; Gene
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
1097-2765
e-ISSN
1097-4164
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 81,
Heft: 14,
Seiten: 2944-2959.e10
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502800-001
Förderungen
Helmholtz Society
ERC
Worldwide Cancer Research
Blood Cancer UK
European Research Council (ERC)
Cancer Research UK Cancer Immunotherapy Network Accelerator (CITA)
Proteomics Research TTP - Cancer Research UK-UCL Centre
UCL Bill Lyons Informatics Centre - Cancer Research UK-UCL Centre
UCL Cancer Institute Genomics TTP
Copyright
Erfassungsdatum
2021-07-22